Status:

COMPLETED

Evaluation of the Neuro-endocrine Response to Post-prandial Hyperinsulinaemic Hypoglycaemia.

Lead Sponsor:

Lia Bally

Conditions:

Roux-en-y Gastric Bypass

Post Prandial Hypoglycemia

Eligibility:

All Genders

18+ years

Brief Summary

The primary objective of this study is to assess the neuro-endocrine response to hypoglycaemia in PHH vs. non-PHH post-gastric bypass individuals.

Detailed Description

Obesity is a major global public health concern, for which the most effective therapy is bariatric surgery. Beyond weight loss, bariatric surgery exerts powerful effects on glucose metabolism, achievi...

Eligibility Criteria

Inclusion

  • Inclusion criteria for PHH patients (Group 1):
  • Aged ≥18 years
  • Roux-en-Y gastric bypass ≥1 year ago
  • PHH defined as postprandial plasma or sensor glucose\<3.0mmol/l according to the International Hypoglycaemia Study Group (1) and exclusion of other causes of hypoglycaemia
  • Inclusion criteria for non-PHH surgical controls (Group 2 and 3):
  • Aged ≥18 years
  • Roux-en-Y gastric bypass (Group 2) or sleeve gastrectomy (Group 3) ≥1 year ago
  • No evidence of PHH
  • Inclusion criteria for non-PHH non-surgical controls (Group 4):
  • Aged ≥18 years
  • Absence of any condition or previous surgery known to affect gastro-intestinal integrity and food absorption
  • Exclusion criteria for all Groups:
  • Clinically relevant weight changes (≥5%) within the past 3 months
  • Incapacity to give informant consent
  • Historical or current diabetes based on HbA1c ≥6.5% without glucose-lowering treatment
  • Haemoglobin level below 13.5 g/l
  • Ongoing treatment with glucose-lowering drugs, anorectic drugs, steroids or any medications known to affect gastric motility
  • Active heart, lung, liver, gastrointestinal, renal or neurological disease
  • Inability to follow study procedures
  • Pregnancy or breast-feeding

Exclusion

    Key Trial Info

    Start Date :

    October 2 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 13 2021

    Estimated Enrollment :

    32 Patients enrolled

    Trial Details

    Trial ID

    NCT04334161

    Start Date

    October 2 2020

    End Date

    July 13 2021

    Last Update

    August 10 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism

    Bern, Switzerland, 3010